北市 伸義 業績集


英文業績(2001年から現在まで)

IF (impact factor): 2018年ISI Journal Citation Reportsより

 

本数

IF合計

一編あたり

First author

17

71.433

4.202

Corresponding author

21

97.606

4.648

Second author

   14

78.067

5.576

その他

77

375.974

4.883

英文全業績

129

623.080

4.830

 
【欧文原著論文】

  1. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida S. Diagnostic accuracy of cell block preparations and clinical features affecting it in vitreoretinal lymphoma. J Clin Med. in press
  2. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease. Ocul Immunol Inflamm. in press
  3. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. in press
  4. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. Epub ahead of print
  5. Iwata D, Namba K, Yamamoto T, Mizuuchi K, Saito W, Ohno S, Kitaichi N, Ishida S. Recent clinical features of intraocular inflammation in Hokkaido, Japan -comparison with the previous decade. Ocul Immunol Inflamm. Epub ahead of print
  6. Hashizume M, Aoki K, Ohno S, Kitaichi N, Yawata N, Gonzalez G, Nonaka H, Sato S, Takaoka A. Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfate. Eur J Ophthalmol. 2021; 31: 379-384
  7. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagnosis & Prognosis. 2021; 1: 69-75
  8. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 971-978
  9. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65: 191-198
  10. Tajiri N, Kato T, Satoh M, Taniguchi M, Kitaichi N, Iwabuchi K. The protective function of invariant natural killer T cells in the relapse of experimental autoimmune uveoretinitis. Exp Eye Res. 2021; 203: 108406
  11. Balt J, Jamyanjav B, Jav S, Dandii Z, Ganbold C, Horie Y, Lenikov A, Zhang A, Uehara O, Ohno S, Kitaichi N. Clinical features of Behcet’s disease in Mongolia: A multicenter study. Clin Rheumatol. 2020; 39: 2697-2706
  12. Balt J, Uehara O, Abiko Y, Jamyanjav B, Jav S, Nagasawa T, Horie Y, Mori M, Fujita M, Lennikov A, Ohta T, Hiraoka M, Iwata D, Namba K, Ohno S, Kitaichi N. Alteration of oral flora in Mongolian patients with Behcet’s disease – A multicenter study. Clin Exp Rheumatol. 2020; 127: 80-85
  13. Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S. Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma. Ocul Immunol Inflamm. 2020; 28: 147–155
  14. Kosehira M, Machida N, Kitaichi N. A 12-week-long intake of bilberry extract (Vaccinium myrtillus L.) improved objective findings of ciliary muscle contraction of the eye: A randomized, double-blind, placebo-controlled, parallel-group comparison trial. Nutrients. 2020; 12 pii: E600
  15. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  16. Machida N, Kosehira M, Kitaichi N. Clinical effects of dietary supplementation of lutein with high bio-accessibility on macular pigment optical density and contrast sensitivity: a randomized double-blind placebo-controlled parallel-group comparison trial. Nutrients. 2020; 12; 2966
  17. Mahendradas P, Maruyama K, Mizuuchi K, Kawali A, Kitaichi N. Multimodal imaging in ocular sarcoidosis. Ocul Immunol Inflamm. 2020; 28: 1205-1211
  18. Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mod Rheumatol. 2020; 30: 708-714
  19. Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimiizu N, Sugita S, Nakamuro T, Hosogai M, Nakatani Y, Sonoda KH, Hasegawa E, Takeda A, Myojin S, Yanai R, Uchi SH, Nagata K, Kaburaki T, Tanaka R, Goto H, Kezuka T, Usui Y, Yamakawa N, Fukuda K, Ishida W, Maruyama K, Hariya T, Namba K, Iwata D, Iwasaki T, Nejima R, Tomomatsu T, Aoki T, Kitaichi N, Horie Y, Takahashi M, Kurimoto Y, Hirami Y. Evaluation of a multiplex Strip PCR test for infectious uveitis: a prospective multi-center study. Am J Ophthalmol. 2020; 213: 252-259
  20. Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, Mizuki N. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japan. PLoS One. 2020; 15: e0233464
  21. Toraya S, Uehara O, Hiraki D, Harada F, Neopane P, Morikawa T, Takai R, Yoshida K, Matsuoka H, Kitaichi N, Chiba I, Abiko Y. Curcumin inhibits the expression of proinflammatory mediators and MMP-9 in gingival epithelial cells stimulated for a proponged period with lipopolysaccharides derived from Porphyromonas gingivalis. Odontology. 2020; 108: 16-24
  22. Aoki K, Gonzalez G, Hinokuma R, Yawata N, Tsutsumi M, Ohno S, Kitaichi N. Assessment of clinical signs associated with adenoviral epidemic keratoconjunctivitis cases in southern Japan between 2011 and 2014. Diagn Microbiol Infect Dis. 2019; 95: 114885
  23. Gonzalez G, Yawata N, Aoki K, Kitaichi N. Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses. J Clin Virol. 2019; 112: 1-9
  24. Ohno T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Association study of ARMC9 gene variants with Vogt-Koyanagi-Harada disease in Japanese patients. Ocul Immunol Inflamm. 2019; 27: 699-705
  25. Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019; 17: 55-59
  26. Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S. Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis. Am J Ophthalmol Case Rep. 2019; 14: 87-91
  27. Maeda-Yamamoto M, Nishimura M, Kitaichi N, Nesumi A, Monobe M, Nomura S, Horie Y, Tachibana H, Nishihira J. A randomized, placebo-controlled study on the safety and efficacy of daily ingestion of green tea (Camellia sinensis L.) cv. “Yabukita” and “Sunrouge” on eyestrain and blood pressure in healthy adults. Nutrients, 2018; 10: 569
  28. Ohtani M, Horie Y, Tagawa Y, Ishida S, Kitaichi N. Patients preference of diquafosol or rebamipide eye drops for the treatment of mild dry eye - a pilot study. Curr Trend Ophtalmol. 2018; 1: 39-45
  29. Harada F, Morikawa T, Lennikov A, Mukwaya A, Schaupper M, Uehara O, Takai R, Yoshida K, Sato J, Horie Y, Sakaguchi H, Wu C-Z, Abiko Y, Lagali N, Kitaichi N. Protective effects of oral astaxanthin nano-powder against ultraviolet-induced photokeratitis in mice. Oxid Med Cell Longev. 2017; 2017: 1956104
  30. Higashi K, Meouro A, Takeuchi M, Yamane T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Tsuneoka H, Keino H, Okada AA, akeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Investigation of association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. Ophthalmic Genet. 2017; 38: 187-189
  31. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  32. Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N. Serial observation and clinical features of uveitis in Hokkaido, Japan. Ocul Immunol Inflamm. 2017; 25: S15-18
  33. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon. 2016; 2: e00191
  34. Horie Y, Kitaichi N, Hijioka K, Sonoda K, Saishin Y, Kezuka T, Goto H, Takeuchi M, Nakamura S, Kimoto T, Shimakawa M, Kita M, Sugita S, Mochizuki M, Hori J, Iwata M, Shoji J, Fukuda M, Kaburaki T, Numaga J, Kawashima H, Fukushima A, Joko T, Takai N, Ozawa Y, Meguro A, Mizuki N, Namba K, Ishida S, Ohno S. Ocular Behçet’s disease is less complicated with allergic disorders. A nationwide survey in Japan. Clin Exp Rheumatol. 2016; 102: 1100-1105
  35. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S. Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol. 2016; 11: 29
  36. Satoh M, Namba K, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda K, Kaer L V, Iwabuchi K. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Exp Eye Res. 2016; 153: 79-89
  37. Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016; 100: 473-477
  38. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015; 34: 321-327
  39. Nagata Y, Yoshihisa Y, Rehman MU, Matsunaga K, Kitaichi N, Shimizu T.Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice. PLoS One. 2015; 10: e0115593
  40. Namba K, Goto H, Kaburaki T, Kitaichi N, Mizuki N, Asukata Y, Fujino Y, Meguro A, Sakamoto S, Shibuya E, Yokoi K, Ohno S. A Major Review: Current Aspects of Ocular Behçet's Disease in Japan. Ocul Immunol Inflamm. 2015; 23: S1-S23
  41. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  42. Gonzalez G, Koyanagi KO, Aoki K, Kitaichi N, Ohno S, Kaneko H, Ishida S, Watanabe H. Intertypic modular exchanges of genomic segments by homologous recombination at universally conserved segments in human adenovirus species D. Gene. 2014; 547: 10-17
  43. Hiraoka M, Abe A, Lennikov A, Kitaichi N, Ishida S, Ohguro H. Increase of lysosomal phospholipase A2 in aqueous humor by uveitis Exp Eye Res. 2014; 118: 13-19
  44. Kaburaki T, Namba K, Sonoda KH, Kezuka T, Keino H, Fukuhara T, Kamoi K, Nakai K, Mizuki N, Ohguro N, Ohno S, Kitaichi N, Keino H, Okada AA, Watanabe T, Takeda A, Ishibashi T, Yawata K, Iwahashi C, Mochizuki M, Sugita S, Goto H, Takamoto M, Nakahara H, Kondo Y, Shibuya E, Kimura I. Behçet’s disease ocular attack score 24: Evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol. 2014; 58: 120-130
  45. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis. 2014; 20: 171-177
  46. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013; 57: 379-384
  47. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczek E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis. 2013; 72: 1510-1516
  48. Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, Ohno S, Ishida S. Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci. 2013;14:2175-2189
  49. Mizuuchi K, Kitaichi N, Namba K, Horie Y, Ishida S, Ohno S. Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013;57:245-251
  50. Saito N, Yoshioka N, Abe R, Qiao H, Fujita Y, Hoshina D, Kase S, Kitaichi N, Ozaki M, Shimizu H. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using of PBMCs and the skin of patients. J Allergy Clin Immunol. 2013;131:434-441
  51. Yamane S, Lee A, Hanaoka N, Gonzalez G, Kaneko H, Ishida S, Kitaichi N, Ohno S, Koyanagi K, Aoki K, Fujimoto T, Yawata N, Watanabe H. Identification of contamination in the American Type Culture Collection stock of human adenovirus type 8 by whole genome sequencing. J Virol. 2013; 87:1285-1286
  52. Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E, Nomura E, Uemoto R, Nishide T, Namba K, Kitaichi N Morimoto S, Kaburaki T, Ando Y, Takenaka S, Nakamura J, Saeki K, Ohno S, Inoko H, MIzuki N. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: Risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci. 2012; 53: 7109-7115
  53. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  54. Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S. Correlation between elevation of serum antinuclear antibody titre and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 1081-1087
  55. Okada AA, Goto H, Ohno S, Mochizuki M, Kitaichi N, Namba K, Keino H, Watanabe T, Ishibashi T, Ito T, Sonoda K, Nakai K, Ohguro N, Sugita S, Kezuka T, Kaburaki T, Takamoto M, Mizuki N. Multicenter study of infliximab for refractory uveoretinitis in Behcet disease. Arch Ophthalmol. 2012; 130: 592-598
  56. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  57. Kitamei H, Namba K, Kitaichi N, Wakayama A, Ohno S, Ishida S. Chickenpox chorioretinitis with retinal exudates and periphlebitis. Case Report Ophthalmol. 2012; 3:180-184
  58. Sakuyama K, Meguro A, Ota M, Ishihara M, Uemoto R, Ito H, Okada E, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Yuasa T, Ohno S, Inoko H, Mizuki N. Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis. 2012; 18: 512-518
  59. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, Ohguchi T, Kawakita T, Ohno S, Ishida S. Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis. 2012; 18: 455-464
  60. Saito M, Yoshida K, Saito W, Fujiya A, Ohgami K, Kitaichi N, Tsukahara H, Ishida S, Ohno S. Astaxanthin increases choroidal blood flow velocity. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 239-245
  61. Jin XH, Aoki K, Kitaichi N, Ariga T, Ishida S, Ohno S. Genome variability of human adenovirus type 8 causing epidemic keratoconjunctivitis during 1986-2003 in Japan. Mol Vis. 2011; 17: 3121-3127
  62. Ito R, Ota M, Meguro A, Katsuyama Y, Uemoto R, Nomura E, Nishide T, Kitaichi N, Horie Y, Namba K, Ohno S, Inoko H, MIzuki N. Investigation of Association between TLR9 Gene Polymorphisms and VKH in Japanese Patients. Ocul Immunol Inflamm. 2011; 19: 202-205
  63. Kaneko H, Aoki K, Ishida S, Ohno S, Kitaichi N, Ishiko H, Fujimoto T, Ikeda Y, Nakamura M, Gonzalez G, Koyanagi KO, Watanabe H, Suzutani T. Recombination analysis of intermediate human adenovirus type 53 in Japan by complete genome sequence. J Gen Virol. 2011; 92: 1251-1259
  64. Aoki K, Benko M, Davison J A, Echavarria M, Erdman D D, Harrach Balazs, Kajon E A, Schnurr D, Arbiza JR, Arnberg N, Binn L, Blair E, Brown M, Carr MJ, Durigon E, Excoffon K, Gonzalez G, Hierholzer JC, Houng HS, Ishiko H, Kaneko H, Kitaichi N, Koyanagi K, Lu X, Mei YF, Metzgar D, Mymryk JS, Myers C, Ohno S, Tellier R, Watanabe H. Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology. J Virol. 2011; 85: 5703-5704
  65. Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Ohno S, Inoko H, Mizuki N. Toll-like receptor2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis. 2011; 17: 731-736
  66. Aoki K, Kaneko H, Kitaichi N, Ohguchi T, Tagawa Y, Ohno S. Clinical features of adenoviral conjunctivitis at the early stage of infection. Jpn J Ophthalmol. 2011; 55: 11-15
  67. Horie Y, Saito W, Kitaichi N, Miura T, Ishida S, Ohno S. Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2011; 55: 57-61
  68. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17:63-69
  69. Tabbara KF, Omar N, Hammouda E, Akanuma M, Ohguchi T, Ariga T, Tagawa Y, Kitaichi N, Ishida S, Aoki K, Ishiko H, Ohno S. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis. 2010; 16: 2132-2136
  70. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R/IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet. 2010; 42: 703-706
  71. Kaneko H, Suzutani T, Aoki K, Kitaichi N, Ishida S, Ishiko H, Ohashi T, Okamoto S, Nakagawa H, Hinokuma R, Asato Y, Oniki S, Hashimoto T, Iida T, Ohno S. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br J Ophthalmol. 2011; 95: 32-36
  72. Iwata D, Kitaichi N, Ebihara A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K. Nuclear factor-κB inhibitor, dehydroxy methyl epoxyquinomicin, ameliorates experimental autoimmune uveoreitnitis in mice. Invest Ophthalmol Vis 2010;51:2077-2084
  73. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei, H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K: Prevention of Experimental Autoimmune Uveoretinitis by Blockade of Osteopontin with Small Interfering RNA. Exp Eye Res. 2010;90:41-48
  74. Kitaichi N, Kitamura M, Namba K, Ishida S, Ohno S. Elevation of surfactant protein D, a pulmonary disease biomarker,in the sera of uveitis patients with sarcoidosis. Jpn J Ophthalmol. 2010 ;5481:84
  75. Asukata Y, Ota M, Meguro A, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Inoko H, Ohno S, Mizuki N. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol Vis 2009; 15: 2673-2682
  76. Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S. Low prevalence of juvenile-onset Behcet’s disease with uveitis in East/South Asian people. Br J Ophthalmol: 93:1428-1430, 2009
  77. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y, Namba K, Yoshida K, Song YW, Park KS, Lee, EB, Inoko H, Mizuki N, Ohno S. Association of TLR4 polymorphism with Behcet disease in Korean population. Rheumatology 48: 638-642, 2009.
  78. Horie Y, Kitaichi N, Katsuyama Y, Yoshida K, Miura T, Ota M, Asukata Y, Inoko H, Mizuki N, Ishida S, Ohno S. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 15: 1115-1119, 2009.
  79. Kitamei H, Kitaichi N, Namba K, Kotake S, Goda C, Kitamura M, Miyazaki A, Ohno S. Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol 87: 424-428, 2009.
  80. Kitaichi N, Shimizu T, Yoshida K, Honda A, Yoshihisa Y, Kase S, Ohgami K, Norisugi O, Makino T, Nishihira J, Yamagishi S-I, Ohno S. Macrophag migration inhibitory factor ameliorates UV-induced photokeratitis in mice. Exp Eye Res 86: 929-935, 2008.
  81. Kitaichi N, Horie Y, Ohno S. Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 246: 1641-1642, 2008.
  82. Taylor AW, Kitaichi N. The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (a-MSH) therapy. Brain Behav Immun. 22: 639-646, 2008.
  83. Miyazaki A, Kitaichi N, Ohgami K, Iwata D, Jin XH, Iwabuchi K, Morohashi T, Ohno S, Onoe K. Anti-inflammatory effect of angiotensin type 1 receptor antagonist on endotoxin-induced uveitis in rats. Graefes Arch Clin Exp Ophthalmol. 246: 747-757, 2008.
  84. Horie Y, Namba K, Kitaichi N, Ohno S. Sister cases of Behcet’s disease and Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 92: 433-434, 2008
  85. Mizuuchi K, Yanagawa Y, Iwabuchi K, Namba K, Kitaichi N, Ohno S, Onoe K. H2-Dd-mediated upregulation of IL-4 production by natural killer T cell and dendritic cell interaction. Immunology. 124: 102-111, 2008
  86. Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S, Ishida T, Ohno S, Mizuki N, Nakashima H, Shirakawa T. Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 71: 564-567, 2008.
  87. Takemoto Y, Naruse T, Namba K, Kitaichi N, Ota M, Shindo Y, Mizuki N, Gul A, Madanat W, Shams H, Davatchi F, Inoko H, Ohno S, Kimura A. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet’s disease. Tissue Antigens. 72: 347-353, 2008.
  88. Dong Z, Namba K, Kitaichi N, Goda C, Kitamura M, Ohno S. Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation. Jpn J Ophthalmol. 52: 374-379, 2008.
  89. Kitaichi N, Miyazaki A, Stanford MR, Chams H, Iwata D, Ohno S. Ocular features of Behcet’s disease: An international collaborative study. Br J Ophthalmol. 91: 1579-1582, 2007
  90. Kitaichi N, Matoba H, Ohno S. The positive role of lumbar puncture in the diagnosis of Vogt-Koyanagi-Harada Disease: lymphocyte subsets in the aqueous humor and cerebrospinal fluid. Int Ophthalmol. 27: 97-103, 2007
  91. Kitamura M, Iwabuchi K, Kitaichi N, Kon S, Kitamei H, Namba K, Yoshida K, Denhardt DT, Rittling S, Ohno S, Uede T, Onoe K. Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol. 178: 6567-72, 2007
  92. Ng TF, Kitaichi N, Taylor AW. In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival. Invest Ophthalmol Vis Sci 48: 5112-5117, 2007
  93. Horie Y, Kitaichi N, Takemoto Y, Namba K, Yoshida K, Hirose S, Hasumi Y, Ota M, Inoko H, Mizuki N, Ohno S. Polymorphism of interferon-g gene and Vogt-Koyanagi-Harada disease. Mol Vis 13: 2334-2338, 2007
  94. Kitamei H, Kitaichi N, Yoshida K, Nakai A, Fujimoto M, Kitamura M, Iwabuchi K, Miyazaki A, Namba K, Ohno S, Onoe K. Association of heat shock protein 70 induction and the amelioration of experimental autoimmune uveoretinitis in mice. Immunobiology 212: 11-18, 2007
  95. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Ocul Immunol Inflamm. 15: 279-294, 2007
  96. Harada C, Nakamura K, Guo X, Kitaichi N, Mitamura Y, Yoshida K, Ohno S, Yoshida H, Harada T. Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury. Mol Vis. 13: 1601-1607, 2007.
  97. Kase S, Yokoi M, Saito W, Furudate N, Ohgami K, Kitamura M, Kitaichi N, Yoshida K, Kase M, Ohno S, Uede T. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy, Ophthalmic Res. 39: 143-147, 2007.
  98. Kitaichi N, Ariga T, Ohno S, Shimizu T. Acute unilateral conjunctivitis after rubella vaccination: The detection of the rubella genome in the inflamed conjunctiva by reverse transcriptase-polymerase-chain reaction. Br J Ophthalmol. 90: 1436-1437, 2006.
  99. Kitaichi N, Ariga T, Kase S, Yoshida K, Namba K, Ohno S. Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 244: 433-437, 2006.
  100. Kitaichi N, Shimizu T, Honda A, Abe R, Ohgami K, Shiratori K, Shimizu H, Ohno S. Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis. Graefes Arch Clin Exp Ophthalmol. 244: 825-828, 2006.
  101. Kase S, Kitaichi N, Namaba K, Miyazaki A, Yoshida K, Ishikura K, Ikeda M, Nakashima T, Ohno S. Elevation of serum KL-6 levels in patients with tublointerstitial nephritis and uveitis (TINU) syndrome. Am J Kidney Dis. 48: 935-941, 2006.
  102. Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoé K. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor kappa B (NF-kappa B), pyrrolidine dithiocarbamate. J Leukoc Biol. 79: 1193-1201, 2006.
  103. Taylor AW, Kitaichi N, Biros DJ. Melanocortin 5 receptor and ocular immunity. Cell Mol Biol. 52: 53-59, 2006.
  104. Kase S, Kitaichi N, Furudate N, Yoshida K, Ohno S. Increased expression of mucinous protein KL-6 in human pterygium. Br J Ophthalmol 90: 1208-1209, 2006.
  105. Kase S, Namba K, Kitaichi N, Ohno S. Epstein-Barr virus-infected cells in the aqueous humor originated from nasal NK/T cell lymphoma. Br J Ophthalmol. 90: 244-245, 2006.
  106. Kase S, Yoshida K, Jin XH, Koyama Y, Kitaichi N, Ohgami K, Shiratori K, Ilieva I, Ohno S. Phosphorylation of p27 (KIP1) in lens epithelial cells after extraction of fiber cells. Int J Mol Med. 18: 1187-1191, 2006.
  107. Kase S, Yoshida K, Sakai M, Ohgami K, Shiratori K, Kitaichi N, Suzuki Y, HaradaT, Ohno S. Immunolocalization of cyclin D1 in the developing lens of c-maf -/- mice. Acta Histochem. 107: 469-472, 2006.
  108. Kitamura M, Kitaichi N, Namba K, Kitamei H, Ohno S. Correspondence – Reply to Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada Disease, Am J Ophthalmol. 141: 778-779, 2006.
  109. Kitaichi N, Namba K, Taylor AW. Inducible immune regulation following autoimmune disease in the immune privileged eye. J Leukoc Biol. 77: 496-502, 2005.
  110. Kitamura M, Kitaichi N, Takeuchi M, Kitamei H, Namba K, Yamagishi S, Iwabuchi K, Onoé K, Ohno S. Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 89: 1407-1409, 2005.
  111. Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada’s disease. Am J Ophthalmol. 139: 1080-1085, 2005.
  112. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW. Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci. 46: 908-919, 2005.
  113. Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 140: 637-641, 2005.
  114. Kase S, Saito W, Yoshida K, Namba K, Osaki M, Ohgami K, Shiratori K, Kitaichi N, Adachi H, Ito H, Ohno S. Expression of thymidine phosphorylase in choroidal malignant melanoma associated with neovascular glaucoma. Pathol Int. 55: 569-573, 2005.
  115. Ohgami K, Ilieva I, Shiratori K, Koyama Y, Jin XH, Yoshida K, Kase S, Kitaichi N, Suzuki Y, Tanaka T, Ohno S. Anti-inflammatory effects of aronia extract against rat endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 46: 275-281, 2005.
  116. Kitaichi N, Kotake S, Shibuya H, Yamada Y, Chiba H, Namba K, Ohno S. Increase of KL-6 in sera of uveitis patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 241: 879-883, 2003.
  117. Kitaichi N, Kotake S, Morohashi T, Onoé K, Ohno S, Taylor AW. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol. 72: 1117-1121, 2002.
  118. Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte stimulating hormone and transforming growth factor-beta2. J Leukoc Biol. 72: 946-952, 2002.
  119. Kitaichi N, Kotake S, Mizue Y, Matsuda H, Onoé K, Nishihira J. Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol. 84: 1423-1425, 2000.
  120. Kitaichi N, Matsuda A, Kotake S, Namba K, Tagawa Y, Sasamoto Y, Ogasawara K, Iwabuchi K, Onoé K, Matsuda H, Nishihira J. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies. Curr Eye Res. 20: 109-114, 2000.
  121. Kitaichi N, Ogasawara K, Iwabuchi K, Nishihira J, Namba K, Onoé K, Konishi J, Kotake S, Matsuda H, Onoé K. Different influence of macrophage migration inhibitory factor (MIF) in signal transduction pathway of various T cell subsets. Immunobiology. 201: 356-367, 2000.
  122. Kitaichi N, Kotake S, Mizue Y, Sasamoto Y, Goda C, Iwabuchi K, Onoé K, Matsuda H, Nishihira J. High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada’s disease. Microbiol Immunol. 44: 1075-1077, 2000.
  123. Namba K, Ogasawara K, Kitaichi N, Morohashi T, Sasamoto Y, Kotake S, Matsuda H, Iwabuchi K, Ohno S, Onoé K. Amelioration of experimental autoimmune uveoretinitis (EAU) by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand mAb. J Immunol. 165: 2962-2969, 2000.
  124. Morohashi T, Ogasawara K, Kitaichi N, Iwabuchi K, Onoé K. Abrogation of negative selection by GVHR induced by minor histocompatibility antigens or H-2D antigen alone. Immunobiology. 202: 268-279, 2000.
  125. Morohashi T, Ogasawara K, Kitaichi N, Iwabuchi K, Onoé K. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from GVHD. Bone Marrow Transpl. 26: 1069-1076, 2000.
  126. Ito D, Ogasawara K, Matsushita K, Morohashi T, Namba K, Matsuki N, Kitaichi N, Inuyama Y, Hosokawa M, Nakayama E, Iwabuchi K, Onoé K. Effective priming of cytotoxic T lymphocyte precursors by subcutaneous administration of peptide antigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies. Immunobiology. 201: 527-540, 2000.
  127. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, Onoé K, Matsuda H, Nishihira J. Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci. 40: 247-250, 1999.
  128. Namba K, Kotake S, Sasamoto Y, Kitaichi N, Matsuda H, Ogasawara K, Onoé K. Identification of an uveitogenic epitope of Interphotoreceptor Retinoid-Binding protein (IRBP) in mice. Uveitis Today. 35-38, 1998.
  129. Namba K, Ogasawara K, Kitaichi N, Matsuki N, Takahashi A, Sasamoto Y, Kotake S, Matsuda H, Iwabuchi K, Ohno S, Onoé K. Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice. Clin Exp Immunol. 111: 442-444, 1998.

【欧文著書・総説】

  1. Kitaichi N. Ultraviolet-induced photokeratitis treated with astaxanthin. Cellular Response to Physical Stress and Therapeutic Application. 2013; 101-103.
  2. Namba K, Goto H, Kaburaki T, Kitaichi N, Mizuki N, Asukata Y, FujinoY, Meguro A, Sakamoto S, Shibuya E, Yokoi K, Ohno S. A major review: Current aspects of ocular Behcet’s disease in Japan. Ocul Immunol Inflamm. 2015; 23: S1
  3. Horie Y, Kitaichi N. Clinical effects of bilberry extract on eyestrain. Occurrences, structure, biosynthesis, and health benefits based on their evidences of medical phytochemicals in vegetables and fruits Vol5. 2016; 97 - 109.
  4. Kitaichi N, Oho S, Dong Z. Sarcoidosis. Case Report 66. 75. Intraocular Inflammation. 2016; 1576.
  5. Ohno S, Kitaichi N, Kitamura M. Sarcoidosis. Chapter 75. Intraocular Inflammation. 2016; 863 - 872.
  6. Kitaichi N, Ohno S. Behcet disease in children. Int Ophthalmol Clin 48: 87-91 Lippincott Williams & Wilkins, West Yarmouth, MA, USA, 2008.
  7. Onoé K, Kitaichi N, Ohno S, Iwabuchi C, Iwabuchi K. NK and NK-T cells possibly involved in Behcet's disease. Immunology of Behcet's Disease. 63-72. Swets & Zeitlinger Publishers, Lisse, The Netherlands, 2003.
  8. Kotake S, Kitaichi N, Ohno S. Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin, 42: 99-103. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2002.